IQV
IQV
IQV
IQV NASDAQ
IQVIA Holdings Inc announced that it has won multiple industry awards for AI and technology innovation across life sciences and healthcare. The company is backed by a full-year revenue of $16.31 billion and a market capitalization of approximately $44.07 billion. Currently, IQVIA trades at a PE ratio of 32.94, supported by a TTM EPS of 8.22 and a free cash flow yield of 5.93%.
Based on businesswire.comIQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now
Callan Family Office LLC Invests $1.75 Million in IQVIA Holdings Inc. $IQV
IQVIA (NYSE:IQV) versus BioLife Solutions (NASDAQ:BLFS) Head to Head Review
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.